Nectar Lifescience Ltd Quarterly Results

Gross Sales

489.32

504.12

497.45

417.51

511.68

Excise Duty

60.41

49.79

69.56

58.66

71.84

Net Sales

428.91

454.33

427.88

358.85

439.85

Other Operating Income

1.79

0.65

0.21

0.45

1.53

Other Income

0.08

0.57

0.69

0.55

1.47

Total Income

430.77

455.56

428.79

359.85

442.84

Total Expenditure

585

410.27

384.76

319.5

392.87

PBIDT

-154.23

45.28

44.02

40.35

49.97

Interest

17.67

17.12

19.81

19.98

24.16

PBDT

-171.9

28.16

24.21

20.38

25.81

Depreciation

15.77

15.61

15.55

15.46

14.7

Minority Interest Before NP

0

0

0

0

0

Tax

0

0

0

0

0

Deferred Tax

-57.58

4.71

3.07

1.95

10.52

Reported Profit After Tax

-130.09

7.84

5.6

2.97

0.59

Minority Interest After NP

0

0

0

0

0

Net Profit after Minority Interest

-130.09

7.84

5.6

2.97

0.59

Extra-ordinary Items

0

0

0

0

0

Adjusted Profit After Extra-ordinary item

-130.09

7.84

5.6

2.97

0.59

EPS (Unit Curr.)

-5.8

0.35

0.25

0.13

0.03

Book Value (Unit Curr.)

0

0

0

0

0

Dividend (%)

0

0

0

0

0

Equity

22.43

22.43

22.43

22.43

22.43

Public Shareholding (Number)

0

0

0

0

0

Public Shareholding (%)

0

0

0

0

0

Pledged/Encumbered - No. of Shares

0

0

0

0

0

Pledged/Encumbered - % in Total Promoters Holding

0

0

0

0

0

Pledged/Encumbered - % in Total Equity

0

0

0

0

0

Non Encumbered - No. of Shares

0

0

0

0

0

Non Encumbered - % in Total Promoters Holding

0

0

0

0

0

Non Encumbered - % in Total Equity

0

0

0

0

0

PBIDTM(%)

-35.95

9.96

10.28

11.24

11.36

PBDTM(%)

-40.07

6.19

5.65

5.67

5.86

PATM(%)

-30.33

1.72

1.3

0.82

0.13